Dow Jones Industrial Average Turns 130 Why the Oldest Stock Index Still Matters Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Regulatory Blocker Genpact CEO Highlights AIDriven Reduction in IT Workload and Employment Growth European Manufacturers Maintain China Production Despite EU DeRisking Rhetoric China Calls for APEC Cooperation as Commerce Minister Skips Opening Due to Urgent Official Business Vickers Insider Trading Report Key Buyers and Sellers for May 26 2026 OFS Credit Company Inc OCCI Q1 2026 Earnings Massive EPS Miss Highlights Credit Portfolio Headwinds CANF Q4 2023 Earnings NarrowerthanExpected Loss Signals Operational Progress CRH Q1 2026 Earnings NarrowerThanExpected Loss Signals Resilience Amid Market Headwinds JOE Q1 2026 Earnings EPS of 024 as Stock Edges Lower CTNM Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress Stock Slightly Down REAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction MediaAlpha MAX Edges Higher in Quiet Trading Holds Near Key Support Blue Bird Corporation BLBD Edges Lower Amid Market Consolidation Bitcoin Infrastructure Acquisition Corp BIXI Holds Steady at 997 Consolidation in Focus rYojbaba Co Ltd RYOJ Faces Sharp 15 Drop as Support Levels Are Tested Invesco Mortgage Capital IVR Edges Lower Amid Broader Mortgage REIT Pressure US Consumer Prices Rise 38 Annually in April Highest Since May 2023 WSBCO Q1 2026 Earnings Preferred Stock Underwhelms Despite Solid EPS Beat Buenaventura Mining BVN Edges Lower as Precious Metals Pull Back CSV Q1 2026 Earnings Slight EPS Beat Amid Mixed Market Reaction Greenidge Generation Holdings 850 Senior Notes GREEL Q1 2025 Earnings Narrowed Loss Exceeds Expectations as Stock Reacts Cautiously SailPoint Q1 2026 Earnings EPS Barely Misses Estimates Shares Rally ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment BETR Q1 2026 Earnings WiderthanExpected Loss as Company Navigates Challenging Market FFIV Q1 2026 Earnings EPS Surges Past Estimates as Software Growth Drives Profitability SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise